Literature DB >> 27781201

Molecular Pathogenesis of Hepatocellular Carcinoma.

Daniel Wai-Hung Ho1, Regina Cheuk-Lam Lo1, Lo-Kong Chan1, Irene Oi-Lin Ng1.   

Abstract

The pathogenesis of hepatocellular carcinoma (HCC) is a multistep process involving the progressive accumulation of molecular alterations pinpointing different molecular and cellular events. The next-generation sequencing technology is facilitating the global and systematic evaluation of molecular landscapes in HCC. There is emerging evidence supporting the importance of cancer metabolism and tumor microenvironment in providing a favorable and supportive niche to expedite HCC development. Moreover, recent studies have identified distinct surface markers of cancer stem cell (CSC) in HCC, and they also put forward the profound involvement of altered signaling pathways and epigenetic modifications in CSCs, in addition to the concomitant drug resistance and metastasis. Taken together, multiple key genetic and non-genetic factors, as well as liver CSCs, result in the development and progression of HCC.

Entities:  

Keywords:  Cancer stem cells; Hepatocellular carcinoma; Molecular alterations; Next-generation sequencing

Year:  2016        PMID: 27781201      PMCID: PMC5075835          DOI: 10.1159/000449340

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  90 in total

1.  TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma.

Authors:  Daniel Wai-Hung Ho; Alan Ka-Lun Kai; Irene Oi-Lin Ng
Journal:  Front Med       Date:  2015-08-14       Impact factor: 4.592

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  High-resolution characterization of a hepatocellular carcinoma genome.

Authors:  Yasushi Totoki; Kenji Tatsuno; Shogo Yamamoto; Yasuhito Arai; Fumie Hosoda; Shumpei Ishikawa; Shuichi Tsutsumi; Kohtaro Sonoda; Hirohiko Totsuka; Takuya Shirakihara; Hiromi Sakamoto; Linghua Wang; Hidenori Ojima; Kazuaki Shimada; Tomoo Kosuge; Takuji Okusaka; Kazuto Kato; Jun Kusuda; Teruhiko Yoshida; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

4.  Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Authors:  Jean Charles Nault; Julien Calderaro; Luca Di Tommaso; Charles Balabaud; Elie Serge Zafrani; Paulette Bioulac-Sage; Massimo Roncalli; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2014-10-27       Impact factor: 17.425

Review 5.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

6.  Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.

Authors:  Thomas Decaens; Cécile Godard; Aurélien de Reyniès; David S Rickman; François Tronche; Jean-Pierre Couty; Christine Perret; Sabine Colnot
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

7.  Identification of driver genes in hepatocellular carcinoma by exome sequencing.

Authors:  Sean P Cleary; William R Jeck; Xiaobei Zhao; Kui Chen; Sara R Selitsky; Gleb L Savich; Ting-Xu Tan; Michael C Wu; Gad Getz; Michael S Lawrence; Joel S Parker; Jinyu Li; Scott Powers; Hyeja Kim; Sandra Fischer; Maha Guindi; Anand Ghanekar; Derek Y Chiang
Journal:  Hepatology       Date:  2013-09-24       Impact factor: 17.425

Review 8.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 9.  Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.

Authors:  Lok-Hei Chan; Steve T Luk; Stephanie Ma
Journal:  Mol Cells       Date:  2015-02-04       Impact factor: 5.034

10.  PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.

Authors:  Valeria Iansante; Pui Man Choy; Sze Wai Fung; Ying Liu; Jian-Guo Chai; Julian Dyson; Alberto Del Rio; Clive D'Santos; Roger Williams; Shilpa Chokshi; Robert A Anders; Concetta Bubici; Salvatore Papa
Journal:  Nat Commun       Date:  2015-08-10       Impact factor: 14.919

View more
  23 in total

1.  Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand.

Authors:  Lingyan Wang; Zhihui Min; Xiangdong Wang; Mushuang Hu; Dongli Song; Zhenggang Ren; Yunfeng Cheng; Yanhong Wang
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

2.  Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma.

Authors:  Daniel Wai-Hung Ho; Wai-Ling Macrina Lam; Lo-Kong Chan; Irene Oi-Lin Ng
Journal:  Front Med (Lausanne)       Date:  2022-07-05

3.  LINC01419-mediated epigenetic silencing of ZIC1 promotes metastasis in hepatocellular carcinoma through the PI3K/Akt signaling pathway.

Authors:  Yifu Hou; Kai Chen; Rui Liao; Youzan Li; Hongji Yang; Jun Gong
Journal:  Lab Invest       Date:  2021-03-26       Impact factor: 5.662

4.  Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.

Authors:  Chenhao Zhou; Wentao Zhang; Wanyong Chen; Yirui Yin; Manar Atyah; Shuang Liu; Lei Guo; Yi Shi; Qinghai Ye; Qiongzhu Dong; Ning Ren
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.

Authors:  Hai Jiang; Yue Zhu; Zhenyu Zhou; Junyang Xu; Shaowen Jin; Kang Xu; Heyun Zhang; Qing Sun; Jie Wang; Junyao Xu
Journal:  Cancer Med       Date:  2018-02-14       Impact factor: 4.452

6.  The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population.

Authors:  Afsaneh Bazgir; Mehdi Agha Gholizadeh; Ayyoob Khosravi; Nader Mansour Samaei
Journal:  Middle East J Dig Dis       Date:  2018-01-10

Review 7.  Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.

Authors:  Erbao Chen; Xiaojing Xu; Ruiqi Liu; Tianshu Liu
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

Review 8.  Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Kumar Jayant; Nagy Habib; Kai W Huang; Jane Warwick; Ramesh Arasaradnam
Journal:  Diagnostics (Basel)       Date:  2020-05-25

9.  Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.

Authors:  Hamid Bakhshi Aliabad; Soudeh Khanamani Falahati-Pour; Hadis Ahmadirad; Maryam Mohamadi; Mohammad Reza Hajizadeh; Mehdi Mahmoodi
Journal:  Biometals       Date:  2018-09-25       Impact factor: 2.949

Review 10.  Biological function and molecular mechanism of piRNA in cancer.

Authors:  Ghanbar Mahmoodi Chalbatani; Hassan Dana; Feridon Memari; Elahe Gharagozlou; Shirin Ashjaei; Peyman Kheirandish; Vahid Marmari; Habibollah Mahmoudzadeh; Farnaz Mozayani; Ali Reza Maleki; Ehsan Sadeghian; Elham Zainali Nia; Seyed Rohollah Miri; Neda Zainali Nia; Omid Rezaeian; Anahita Eskandary; Narges Razavi; Mohammad Shirkhoda; Fatemeh Nouri Rouzbahani
Journal:  Pract Lab Med       Date:  2018-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.